Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.

Frohman, Elliot M; Stüve, Olaf; Havrdova, Eva; Corboy, John; Achiron, Anat; Zivadinov, Robert; Sorensen, Per Soelberg; Phillips, J Theodore; Weinshenker, Brian; Hawker, Kathleen; Hartung, Hans-Peter; Steinman, Lawrence; Zamvil, Scott; Cree, Bruce A C; Hauser, Stephen; Weiner, Howard; Racke, Michael K; Filippi, Massimo

Frohman, Elliot M; Stüve, Olaf; Havrdova, Eva; Corboy, John; Achiron, Anat; Zivadinov, Robert; Sorensen, Per Soelberg; Phillips, J Theodore; Weinshenker, Brian; Hawker, Kathleen; Hartung, Hans-Peter; Steinman, Lawrence; Zamvil, Scott; Cree, Bruce A C; Hauser, Stephen; Weiner, Howard; Racke, Michael K; Filippi, Massimo.

Affiliation

Frohman EM; Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. elliot.frohman@utsouthwestern.edu

Arch Neurol ; 62(10): 1519-30, 2005 Oct.

Article in En | MEDLINE | ID: mdl-16216934

Subject(s)

Multiple Sclerosis/therapy; Disease Progression; Humans; Randomized Controlled Trials as Topic

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis Type of study: Clinical_trials Limits: Humans Language: En Journal: Arch Neurol Year: 2005 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links